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Atopic dermatitis (AD) is a common chronic skin disease that is characterized by intense pruritus and has
high impairment of quality of life. AD is often described as “the itch that rashes, rather than the rash that
itches”. Several studies suggest that mechanisms of central modulation play an important role in the
development and maintenance of chronic itch. Therefore, treating the neurosensory aspects of itch is an
important part in the management of chronic itch. However, little attention has been paid to the role of
the central nervous system in the processing of itch in AD. Targeting itch-related anatomical structures in
the brain with non-invasive treatments such as psychological interventions and transcranial Direct
Current Stimulation (tDCS) could have an antipruritic effect in AD. Therefore, in this review article, we
discuss the current progress in brain imaging research of itch, as well as the efﬁcacy of non-invasive
interventions for itch relief in this patient group.
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Atopic dermatitis (AD) is a skin disease characterized by other
atopic diseases in the patient and/or their family members,
licheniﬁcation at certain sites of the body, and a chronically re-
lapsing course.1 Itch is a cardinal symptom of this skin disease1
which bothers many patients in the evening and at night and can
prevent the patients from falling asleep.2 The response to an itch is
usually scratching, which exacerbates inﬂammation through me-
chanical stimulation3 and ﬁnally exacerbates itch. This leads to the
development of a vicious cycle of itching and scratching. Feelings of
unattractiveness, stigmatization, and depression are common
phenomena in AD patients.4,5 Thus, it is not surprising that patients
with AD often report suffering from a reduced health related-
quality of life.6
There are several studies that investigated the underlying
physiological processes of AD itch. Many of these studies focused on
genetic abnormalities, immunological dysfunctions, or deﬁciencies
in the skin barrier function.7 On the other hand, there are only a
handful of studies focusing on the cerebral mechanisms of itch in
patients with AD. Some studies report that psychological in-
terventions are effective for chronic itch.8 It was also reported that
non-invasive brain stimulation interventions such as transcranial
Direct Current Stimulation (tDCS) could reduce itch.9 These studies
suggest that the brain is an important target for the treatment of
itch in AD. Therefore, in this article we review the current progress
in neuroimaging research of itch, and discuss the efﬁcacy of psy-
chological interventions and non-invasive brain stimulation for itch
relief.Fig. 1. Brain regions associated with itch. SI, primary somatosensory cortex; SII, secondary s
cortex; PCC, posterior cingulate cortex; aIC, anterior part of the insular cortex; pIC, posterior
midcingulate cortex; Str, striatum. MRI images: 2D images of the brain template implemenThe cerebral mechanism of itch
Human brain imaging studies of itch
The ﬁrst study investigating the cerebral mechanism of itch was
published in 1994.10 Since then, several brain imaging studies have
been conducted using positron emission tomography (PET), func-
tional magnetic resonance imaging (fMRI), electroencephalography
(EEG), and magnetoencephalography (MEG).10e20 Most of these
studies have investigated the cerebral response to an itch stimulus
using pruritogens (e.g., histamine, or cowhage) or electrical itch
stimuli in healthy subjects. The somatosensory cortex, cingulate
cortex, medial parietal cortex, insular cortex (IC), and motor cortex
are considered to be key brain regions associated with itch
perception and scratching (Fig. 1). Thus, these regions are discussed
in detail in the following paragraphs.
Somatosensory cortex
The somatosensory cortex receives projections from the spinal
cord through the thalamus. It is divided into two regions: One is the
primary somatosensory cortex (SI), which is located in the post-
central sulcus, the other is the secondary somatosensory cortex
(SII), which is located within the upper part of the lateral sulcus in
the region of the parietal operculum. Previous brain imaging
studies have demonstrated that the SI and SII are activated by itch
stimuli. In general, the somatosensory cortex is considered to be
associated with perception of intensity and location of somato-
sensory input. In fact, the SI represents the sensory homunculus
(i.e., a physical representation of the human body) and the SII alsoomatosensory cortex; Th, thalamus; ACC, anterior cingulate cortex; MCC, midcingulate
part of the insular cortex; SMA, supplementary motor area; PM, premotor cortex; MCC,
ted in the MRIcron software (http://www.mccauslandcenter.sc.edu/mricro/).
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location of SI activation by itch stimuli corresponded to the arm
area (site of the itch stimuli) of the homunculus. Drzezga et al. re-
ported that activity in the SI positively correlated with the intensity
of itch stimuli.11 This was consistent with the results of other
studies that found a linear relationship between the neural
response of the SI and the intensity of the somatosensory stim-
uli.22e26 The SII site did not show such a linear relationship. Activity
in this region exhibited an S-shaped function with a sharp increase
in amplitude only when a stimuli's intensity was well above the
pain threshold.22e26 Thus, some researchers consider that the SI
plays a more important role for the intensity coding of somato-
sensory stimuli. However, it is still uncertain if the neural response
of the SI represents the intensity of all perceived somatic
sensations.Cingulate cortex
The cingulate cortex can be divided into three regions: the
anterior cingulate cortex (ACC), midcingulate cortex (MCC), and
posterior cingulate cortex (PCC). In previous brain imaging studies
of itch, robust activation was observed in the MCC or posterior part
of the ACC during itch stimuli.10e12,17,20 These regions are associated
with cognition, motivation, and movement rather than emotional
processing.27,28 These activations in the cingulate cortex are likely
to be associated with cognition/evaluation of itch stimuli and/or
the urge to scratch.Medial parietal cortex
The medial parietal cortex including the precuneus and PCC is
located on the inside between the two cerebral hemispheres (Figs.1
and 2). Previous brain imaging studies of itch frequently observed
activation of the medial parietal cortex.13,17,19,20,29 This region may
be selective for itch, as it is less sensitive to other somatosensory
stimuli, including tactile and painful stimuli.30 It was reported that
pain sensitivity is inversely related to regional grey matter density
in the medial parietal cortex.31 In addition, it was reported that
activity in the medial parietal cortex was modulated during the
modulation of pain by hypnosis, speculating that this region mayFig. 2. Comparison of brain activity during itch stimuli between AD patients and healthy c
(pre-)cuneus, exhibited a signiﬁcantly higher reaction to itch stimuli in the AD patient group
by Ishiuji et al. published in British Journal of Dermatology.19partly be involved in this analgesic effect.32,33 An fMRI study of itch
reported that activity in the precuneus is signiﬁcantly and posi-
tively correlated with subjective sensations of itch.17 Considering
these ﬁndings, the medial parietal cortex may be associated with
the subjective sensations of itch and pain. The medial parietal
cortex is associated with memory and attention.34 These psycho-
logical factors may inﬂuence itch and pain sensations.Insular cortex
The anterior and posterior ICs have different roles. The anterior
part is considered to be more engaged in awareness of emotion and
subjective feelings, whereas the posterior part is considered to be
associated with awareness of affective body feelings (e.g., pain,
cold, thirst).35 Lesions in the anterior part of the IC (aIC) lead to
deﬁcits of emotional awareness (e.g., alexithymia),36 and lesions in
the posterior part of the IC (pIC) induced a loss of bodily feelings
(e.g., anosognosia)37 and abnormal bodily feelings, such as spon-
taneous pain.38 An fMRI study showed that subjective feelings of
perceived thermal sensations and physical stimulus intensity of the
thermal stimuli were signiﬁcantly correlatedwith activity in the aIC
and pIC, respectively.39 Previous itch studies observed activations
of both parts of the ICs during itch stimuli.13,14,16,17,20 The pIC is one
of the major cortical targets of the spinothalamic tract (STT),40
which transmits itch signals to the brain.41,42 In accordance with
this anatomical pathway, only the pIC showed a signiﬁcant corre-
lation between its activity and the physical intensity of itch stim-
uli.11 On the other hand, several studies reported that activity in the
aIC was signiﬁcantly and positively correlated with the subjective
itch sensation and unpleasantness of itch.13,16,17,20,27Motor cortex
The motor cortex (motor-related cortical areas) including the
supplementary motor area (SMA), premotor cortex (PM), and pri-
mary motor cortex (MI) are activated by itch stimuli. Interestingly,
these activations are independent of a scratching response, as no
movements were allowed to subjects during PET or fMRI mea-
surements. Simply imagining movement induces activation of the
motor cortex.43,44 In addition, human EEG and animalontrols. The medial parietal cortex, including the posterior cingulate cortex (PCC) and
when compared with the healthy control group. This ﬁgure is adapted from the article
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cortex is activated a few seconds before motor initiation, which is
known as “readiness potential” or “Bereitschaftspotential”.45e47
Based on these ﬁndings, the motor cortex is considered to be
associated not only with motor execution, but also with its prepa-
ration. The motor cortex has anatomical connections with the
striatum, which is also activated by itch stimuli and plays an
important role in motivation and motor control. Co-activations of
these regions during itch stimuli may reﬂect both motor prepara-
tion for scratching and urge to scratch.
Histaminergic vs. non-histaminergic itch
The major ascending pathway to mediate itch sensations is the
STT, which can be divided into two pathways. One is a histamin-
ergic pathway and the other is a non-histaminergic pathway. The
non-histaminergic pathway has protease-activated receptors2
(PAR2) that can be exogenously stimulated by spicules of cowhage
(Mucuna pruriens).48 The itch sensation transmitted by these
pathways activates common brain regions including the SI, SII, IC,
thalamus, and motor-related regions. Of note, cowhage evokes a
more extensive activation of the IC, claustrum, globus pallidus,
caudate body, putamen, and thalamic nuclei on the contralateral
side of the stimuli (Fig. 3).20 These differences may be related not
only to an intrinsic speciﬁcity in cortical projection, but also to the
ﬂuctuating quality and associated nociceptive signaling (e.g.,
stinging, burning) elicited by cowhage. These sensations are
frequently reported in many cases of chronic itch in AD.
Brain activity in AD patients
As outlined above, there are several studies that investigated
which brain areas are activated during itch. Only two studies haveFig. 3. Brain activity during histaminergic- and nonhistaminergic-itch stimuli in healthy ind
Green: Histaminergic itch. ACC, anterior cingulate cortex; PCC, posterior cingulate cortex; SP
SMG, supramarginal gyrus; MTG, middle temporal gyrus; IPL, inferior parietal lobule; S2, se
ﬁgure is adapted from the article by Papoiu et al. published in Neuroimage.20investigated the similarities and differences in brain activation
patterns associated with itch between AD patients and healthy
subjects. Overall, itch induction in AD patients resulted in a more
diffuse pattern of activation when compared to healthy subjects.49
One of the studies was able to show a positive correlation between
disease severity (as measured by a standardized clinical measure;
EASI score) and activations of the ACC and dorsolateral prefrontal
cortex (DLPFC).19 Furthermore, this study reported an overreaction
to itch stimuli in the medial parietal cortex of AD patients (Fig. 2).
The medial parietal cortex is associated with memory34 and AD
patients have many experiences of severe itch in their lives, which
would be deeply ingrained within the memory system in the brain.
Perhaps, past itch experiences are unconsciously or consciously
retrieved, which modulates (i.e., enhances) subjective itch sensa-
tions. In fact, AD patients perceive a real itch sensation even when
they watch scratching behavior of others, with the response being
signiﬁcantly more robust in comparison to healthy controls.50 In a
pain study, it was reported that pain hallucination is partly asso-
ciatedwith activation of themedial parietal cortex, speculating that
the memory system may have a capability to create real somatic
sensations.51
The other study comparing AD brain activity to healthy controls,
reported signiﬁcantly higher activity in the basal ganglia, including
the striatum, for patients with AD.18 Also, a study investigating the
difference in brain activity after evoked itch in nonlesional versus
lesional skin of AD patients found the basal ganglia to be signiﬁ-
cantly activated after histamine-induced itch was induced on
lesional skin.52 Activation in the basal ganglia is associated with
motivation and craving. An over activity in this region could
possibly explain the excessive, pathological scratching commonly
seen in AD patients. Other fMRI study also investigated the un-
derlying cerebral mechanism of this phenomenon by comparingividuals. Red: The overlap of brain activations, Blue: Nonhistaminergic itch (cowhage),
L, superior parietal lobule; M1, primary motor cortex; S1, primary somatosensory area;
condary somatosensory area; VPL, ventral posterior lateral nucleus (of thalamus). This
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healthy controls.53 In this study, the subjects themselves scratched
the skin where cowhage-induced itch was evoked. Motor-related
regions such as the SMA, PM, MI, and MCC were signiﬁcantly
activated during scratching in both groups. However, activity in
these regions was signiﬁcantly higher in the patient group, which
included several AD patients (Fig. 4a). A similar result was also
observed even when the skin was scratched in the absence of itch
(Fig. 4b). In addition, the intensity of activity in motor-related re-
gions during scratching was signiﬁcantly and positively correlated
with the intensity of pleasurable sensations in the patient group.
This signiﬁcant positive correlation suggested that scratching-
induced pleasurability augmented activity in motor-related re-
gions irrespective of whether the skin was itchy or not. The
enhanced activity in motor-related regions may drive excessive
scratching, seen in chronic itch patients. Another interesting
ﬁnding was that an intense pleasurable sensation was evoked by
scratching the skin even in the absence of itch in the patient group.
In contrast, scratching the skin without itch does not induceFig. 4. Active scratching-induced activations in the brain. Brain regions signiﬁcantly activate
Prec, precuneus; PCC, posterior cingulate cortex; SMA, supplementary motor area; MCC, m
Mochizuki et al. published in Journal of Investigative Dermatology.53pleasurable sensations in healthy subjects. Thus, scratching is
pleasurable for chronic itch patients, even in the absence of itch,
and this could be one of the reasons why these patients frequently
scratch their skin.
The duration of chronic itch and scratching may also have
induced abnormalities. MRI studies with chronic pain and end
stage renal disease pruritus patients have demonstrated structural
changes in brain regions involved in pain and itch processing,
respectively.54e56 Considering these studies, long term suffering
from chronic itch may induce not only functional, but also struc-
tural abnormalities in AD patients, which could possibly be affected
by non-invasive treatment like psychological interventions.
Psychological interventions as treatment of itch in AD
A few studies summarized which psychological interventions
had positive effects on itch and scratching in AD patients.57,58
Ehlers et al. compared the effects of four different interventions
on itch and scratching in AD patients.8 Patients either receivedd during scratching an itch (a) and during scratching the skin in the absence of itch (b).
idcingulate cortex; OFC, orbitofrontal cortex. This ﬁgure is adapted from the article by
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treatment (BT), dermatological education plus behavioral treat-
ment (DEBT), or standard medical care (SMC). Each intervention
lasted 12 weeks with weekly sessions, which took about 1.5e2 h
each. Patients of all four groups showed an improvement in itch
and scratching one year after treatment, when comparing to the
pre-treatment values. Moreover, results indicated that patients of
the DEBT group reported larger reductions in the frequency of itch
and scratching than patients of the AT- or DE-groups. Evers et al.
conducted a study, in which they investigated the effects of a
multidisciplinary itch-coping program on itch, scratching, and the
intake of itch-relieving medication immediately after treatment, as
well as three and twelve months after treatment.59 The study
included 61 adult AD patients who took part in the program and 30
patients who were members of a waiting-list-control group. The
intervention group participated in four 2-h sessions, in which self-
monitoring techniques of itch and scratching, itch- and scratch
triggering factors, as well as coping strategies and habit-reversal
techniques were discussed. A booster session, which took place
one month after the last session, was conducted to discuss long-
term goals and how to prevent relapse. Immediately after the end
of the training, as well as during the 3- and 12-month follow-up,
the patients of the intervention group reported signiﬁcantly less
itch and scratching (divided into conscious scratching, automatic
scratching and scratching at night) than the waiting-list-control
group. In another study by Bae et al., 25 AD patients were
randomly assigned to either a control group or an intervention
group that conducted a progressive muscle relaxation training at
home twice a day for four weeks.60 After the training, the inter-
vention group displayed a signiﬁcant reduction in itch, while the
itch intensity in the control group was unchanged.
As these studies do not investigate the effects on brain activity it
may be possible to learn from studies of patients with chronic pain
given the similarities between chronic pain and chronic itch.61 A
recently published review nicely summarizes the effects of psy-
chological interventions on brain mechanisms in chronic pain pa-
tients.62 There are several studies that found different kinds of
psychological interventions like cognitive behavioral therapy,
meditation, or biofeedback lead to functional and structural
changes of the brain in patients with chronic pain. Lackner et al.
conducted one of the ﬁrst studies on the effects of pain modulation
through psychological interventions on brain mechanisms.63 They
were able to demonstrate that patients with irritable bowel syn-
drome beneﬁted from group cognitive therapy aiming to reduce
gastrointestinal symptoms and stress by identifying and replacing
maladaptive, catastrophizing disease-related thoughts. In this
study patients displayed a reduced activity in the parahippocampal
gyrus and right ACC after treatment.
In addition to cognitive therapy, practicing mindfulness has
also been shown to be associated with distress in patients with
skin diseases64 and at the same time to reduce pain65,66 and affect
brain structures in chronic pain patients.67 Mindfulness relates to
focusing on the current moment and includes the notions that the
body and the surroundings are perceived, and that one's own
feelings and thoughts are observed and accepted without being
judged.68 Studies using mediation, similar to mindfulness, showed
that expert meditators had a different response to pain stimuli
than those without experience in meditation.69 In expert medi-
tators the experience of pain stimuli was accompanied with an
increased activity of the “salience network”, which according to
Lutz et al. comprises the left aIC and the anterior part of the
MCC.69 Besides differences in functional brain activity, meditators
also displayed a lower sensitivity to pain that was related to
thicker cortex in the right dorsal ACC, hippocampal formation, SII,
and IC.67In future, randomized, controlled studies it would be of great
interest to investigate the effects of psychological interventions like
CBT, mindfulness based stress reduction (MBSR), or relaxation on
brain activity in patients with chronic itch. One could assume that a
different attitude towards symptoms, which can be evoked by
MBSR, would lead to a deactivation of cognition-related activity of
the ACC or MCC during itch. On the other hand, other psychological
approaches aiming to reduce scratching, like habit-reversal
training, might not go along with a deactivation of motor-related
regions like the SMA, since the urge to act (“Bereitschaftspoten-
tial”) would still be there and only the following scratch response
would be changed through the training. Furthermore, it is
reasonable to assume that psychological interventions aiming to
reduce stress would also have a positive effect on itch and alter the
activity of itch-related brain structures, such as the ACC or IC.
Non-invasive brain stimulation as treatment of itch in AD
Another treatment option for chronic itch may be non-invasive
brain stimulation, such as repetitive Transcranial Magnetic Stimu-
lation (rTMS) and tDCS. Using these techniques one can manipulate
neural activity in a human brain by applying weak magnetic or
electrical stimuli through the scalp. These techniques are consid-
ered safe, with minimal side effects. Many studies have been done
to investigate the effect of rTMS or tDCS on experimentally induced
pain in healthy subjects, as well as in those suffering from chronic
pain.70e76 These studies have demonstrated that rTMS and tDCS
have an analgesic effect by modulating activity in brain regions
involved in pain processing. Considering the similarity of the
mechanisms between pain and itch, non-invasive brain stimulation
may also be able to reduce chronic itch. However, the efﬁcacy of
tDCS and rTMS for itch relief has been inadequately investigated.
The effect of a tDCS intervention on experimentally induced acute
itch (histamine-induced itch) was ﬁrst investigated in 2015.9 In this
study, electrodes of tDCS were placed over the sensorimotor cortex
(mainly the SI) and an electrical current of 1 mA was applied for
15 min. This study found a signiﬁcant reduction of the itch sensa-
tion during the tDCS intervention. Similar to studies investigating
the effect of a tDCS intervention on experimentally induced acute
pain, the effect size was not large (e.g., 25% reduction). These
studies applied tDCS only once to evaluate the analgesic and anti-
pruritic effects. On the other hand, clinical studies showed signiﬁ-
cant analgesic effects on chronic pain and reported approximately
50% reductions in chronic pain from several days to several
weeks.75,77 Unlike other studies on experimentally-induced pain,
clinical studies employed repeated application (e.g., 5e10 days) of
tDCS.72,75,77e79 Thus, we expect that repeated application of tDCS
might be important in order to observe clinically meaningful
antipruritic effects. In fact, a case report described that a tDCS
intervention over the primary somatosensory or motor cortex for 5
consecutive days induced a clinically meaningful antipruritic effect
in a patient with chronic itch due to neuropathy.80 A potential
mechanism behind itch relief by tDCS intervention over the SI may
be that it modulates itch-related processing in the brain, since the
SI has anatomical connections to the SII, striatum, and thalamus.
However, as of yet, no study has investigated the underlying ce-
rebral mechanism of itch relief by tDCS targeting the SI or MI.
Conclusion
AD is a chronic skin disease of intense itch and scratching. Im-
aging studies have found functional and structural abnormalities in
brain areas associated with itch-related processing. As there are
few studies that imaged the brain in atopic eczema patients future
studies should further investigate the brain processing of itch and
H. Mochizuki et al. / Allergology International 66 (2017) 14e2120scratching in AD. Moreover, in order to compliment the immune
mediated treatments, AD patients should receive, non-invasive and
non-pharmacological treatments, such as psychological in-
terventions, rTMS, or tDCS, which can attenuate brain processing of
itch.Conﬂict of interest
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